Navigating the U.S. regulatory landscape for neurologic digital health technologies
Digital health technologies (DHTs) can transform neurological assessments, improving quality and continuity of care. In the United States, the Food & Drug Administration (FDA) oversees the safety and efficacy of these technologies, employing a detailed regulatory process that classifies devices...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-04-01
|
| Series: | npj Digital Medicine |
| Online Access: | https://doi.org/10.1038/s41746-024-01098-5 |